NCCN Collaborates with Pfizer on Program Focused on Health Care Quality Improvement and Education
NCCN and Pfizer will elicit proposals for quality improvement and education in rare cancer types; Grants to provide funding for approximately nine proposals focused on patients with renal cell carcinoma or hematologic malignancies
FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) is collaborating with Pfizer Independent Grants for Learning & Change (IGLC) to establish a peer-reviewed grant program to elicit proposals focused on heal...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Education | Funding | Grants | Health | Health Management | Hematology | Kidney Cancer | Learning | Pfizer | Renal Cell Carcinoma | Universities & Medical Training